Identification of deleterious mutation in CHEK2 gene an insilico approach

被引:0
|
作者
Punyadeep [1 ]
Singh, Priyanka [1 ]
Sudandiradoss, C. [1 ]
机构
[1] VIT Univ, Sch Biol Sci & Technol, Vellore 632014, Tamil Nadu, India
来源
HELIX | 2012年 / 3卷
关键词
CHEK2; gene; SIFT; PolyPhen; I-Mutant;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Single-nucleotide polymorphisms (SNPs) play a major role in the understanding of the genetic basis of many complex human diseases. The current study reports. of the total of 682 SNPs in the CHK2 gene. 10 non-svnonvmous SNPs (nsSNPs) were identified as functionally significant. SIFT, PolyPhen and I -Mutant programs were used to analyze the nsSNPs. Out of total 10 nsSNPs, 8 were found to be deleterious by SIFT and 5 were damaging as per the PolyPhen program. The complete analysis of these mutations has been the focus of the paper. The structural stability of the mutated structures was studied using I- Mutant program. From a comparison of the stabilizing residues of the native and mutant proteins. we propose that the nsSN P rs121908706. rs121908705, rs121908701, rs112032633and rs111292981) could be important candidates for the various cancers caused by the mutation in CHEK2 gene.
引用
收藏
页码:173 / 176
页数:4
相关论文
共 50 条
  • [31] Bilateral Paget's Disease of the Breast in a Patient with CHEK2 Mutation
    Owusu-Brackett, Nicci
    Menon, Preethi Dileep
    Nazarullah, Alia
    Jatoi, Ismail
    Elmi, Maryam
    EUROPEAN JOURNAL OF BREAST HEALTH, 2020, 16 (02) : 152 - 154
  • [32] Can selenium be a modifier of cancer risk in CHEK2 mutation carriers?
    Gupta, Satish
    Jaworska-Bieniek, Katarzyna
    Lubinski, Jan
    Jakubowska, Anna
    MUTAGENESIS, 2013, 28 (06) : 625 - 629
  • [33] CHEK2 mutation in a patient with pancreatic adenocarcinoma -a rare case report
    Vittal, Anusha
    Saha, Debbie
    Samanta, Ipsita
    Kasi, Anup
    AME CASE REPORTS, 2021, 5
  • [34] Limited relevance of the CHEK2 gene in hereditary breast cancer
    Dufault, MR
    Betz, B
    Wappenschmidt, B
    Hofmann, W
    Bandick, K
    Golla, A
    Pietschmann, A
    Nestle-Krämling, C
    Rhiem, K
    Hüttner, C
    Von Lindern, C
    Dall, P
    Kiechle, M
    Untch, M
    Jonat, W
    Meindl, A
    Scherneck, S
    Niederacher, D
    Schmutzler, RK
    Arnold, N
    INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (03) : 320 - 325
  • [35] Case Report of an Adrenocortical Carcinoma Associated With Germline CHEK2 Mutation
    Xie, Changqing
    Tanakchi, Sally
    Raygada, Margarita
    Davis, Jeremy L.
    Del Rivero, Jaydira
    JOURNAL OF THE ENDOCRINE SOCIETY, 2019, 3 (01): : 284 - 290
  • [36] CHEK2* 1100delC Mutation and Risk of Prostate Cancer
    Hale, Victoria
    Weischer, Maren
    Park, Jong Y.
    PROSTATE CANCER, 2014, 2014
  • [37] Association of two mutations in the CHEK2 gene with breast cancer
    Bogdanova, N
    Enssen-Dubrowinskaja, N
    Feshchenko, S
    Lazjuk, GI
    Rogov, YI
    Dammann, O
    Bremer, M
    Karstens, JH
    Sohn, C
    Dörk, T
    INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (02) : 263 - 266
  • [38] Germline mutation of CHEK2 in neurofibromatosis 1 and 2 Two case reports
    Li, Qiang
    Zhao, Feilong
    Ju, Yan
    MEDICINE, 2018, 97 (23)
  • [39] Variant of the CHEK2 gene as a prognostic marker in glioblastoma multiforme
    Simon, Matthias
    Ludwig, Michael
    Fimmers, Rolf
    Mahlberg, Ralph
    Mueller-Erkwoh, Angelika
    Koester, Gertraud
    Schramm, Johannes
    NEUROSURGERY, 2006, 59 (05) : 1078 - 1085
  • [40] CHEK2: the third susceptibility BReast CAncer (BC) gene?
    Gomes, V. L.
    Machado, P.
    Fragoso, S.
    Santos, S.
    Coelho, I.
    Parreira, J.
    Rodrigues, P.
    Rodrigues, F.
    Clara, A.
    Bento, S.
    Luis, A.
    Opiniao, A.
    Vaz, F.
    CANCER RESEARCH, 2019, 79 (04)